Contura Vet at London Vet Show
Discover Arthramid at London Vet Show 2025
Join us at Europe’s premier veterinary event and discover how Arthramid® is transforming joint health across the globe.
The London Vet Show presents an exclusive opportunity for European veterinarians to explore the science behind Arthramid’s innovative 2.5% injectable polyacrylamide hydrogel (iPAAG) technology. As the first and only treatment designed to target the synovium directly, Arthramid offers a new approach to managing osteoarthritis and joint lameness in both equine and canine patients.
Hear from Dr. Jason Lowe – Arthramid’s Chief Veterinary Officer and Managing Director in two mini lectures at the event:
Reframing 2.5%: iPAAG Insights Into the Mechanism and Medicine of Its Role in OA Therapy
Thursday 20 Nov 2025 | 14:00–15:00
Rethinking OA Therapy: 2.5% iPAAG as a Novel OA Modulator
with Matt Brunke (VetDVM, DACVSMR, Fellow IAVRPT)
Friday 21 Nov 2025 | 10:45–11:45
Dr. Lowe will be at the Nupsala stand (H10) throughout the event and is available to discuss:
- Clinical applications and case selection for Arthramid
- Latest research findings from Colorado State University
- Real-world outcomes from veterinary practices across Europe
- Integration of Arthramid into your treatment protocols
Whether you’re looking to expand your joint health offerings or seeking evidence-based solutions for challenging lameness cases, this is your chance to engage directly with the clinical expertise behind Arthramid’s success.
Don’t miss this opportunity to advance your approach to joint health management.